Literature DB >> 32892392

Effect of single- versus double-layer uterine closure during caesarean section on postmenstrual spotting (2Close): multicentre, double-blind, randomised controlled superiority trial.

S I Stegwee1, L F van der Voet2, A J Ben3, R A de Leeuw1,4, P M van de Ven5, R G Duijnhoven4, M Y Bongers6, C B Lambalk1, Cjm de Groot1,4, Jaf Huirne1,4.   

Abstract

OBJECTIVE: To evaluate whether double-layer uterine closure after a first caesarean section (CS) is superior compared with single-layer uterine closure in terms of postmenstrual spotting and niche development in the uterine caesarean scar.
DESIGN: Multicentre, double-blind, randomised controlled superiority trial.
SETTING: Thirty-two hospitals in the Netherlands. POPULATION: A total of 2292 women aged ≥18 years undergoing a first CS were randomly assigned to each procedure (1:1): 1144 women were assigned to single-layer uterine closure and 1148 women were assigned to double-layer uterine closure.
METHODS: Single-layer unlocked closure and double-layer unlocked closure, with the second layer imbricating the first. MAIN OUTCOME MEASURES: Number of days with postmenstrual spotting during one menstrual cycle 9 months after CS. SECONDARY OUTCOMES: perioperative and menstrual characteristics; transvaginal ultrasound measurements.
RESULTS: A total of 774 (67.7%) women from the single-layer group and 770 (67.1%) women from the double-layer group were evaluable for the primary outcome, as a result of drop-out and amenorrhoea. The mean number of postmenstrual spotting days was 1.33 (bootstrapped 95% CI 1.12-1.54) after single-layer closure and 1.26 (bootstrapped 95% CI 1.07-1.45) after double-layer closure (adjusted mean difference -0.07, 95% CI -0.37 to 0.22, P = 0.810). The operative time was 3.9 minutes longer (95% CI 3.0-4.9 minutes, P < 0.001) and niche prevalence was 4.7% higher (95% CI 0.7-8.7%, P = 0.022) after double-layer closure.
CONCLUSIONS: The superiority of double-layer closure compared with single-layer closure in terms of postmenstrual spotting after a first CS was not shown. Long-term obstetric follow-up of our trial is needed to assess whether uterine caesarean closure guidelines should be adapted. TWEETABLE ABSTRACT: Double-layer uterine closure is not superior for postmenstrual spotting after a first caesarean; single-layer closure performs slightly better on other outcomes.
© 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Caesarean section; double layer; niche; postmenstrual spotting; single layer; uterine closure technique

Year:  2020        PMID: 32892392     DOI: 10.1111/1471-0528.16472

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

1.  How to perform standardized sonographic examination of uterine niche in non-pregnant women.

Authors:  C Verberkt; I P M Jordans; T Van den Bosch; D Timmerman; T Bourne; R A de Leeuw; J A F Huirne
Journal:  Ultrasound Obstet Gynecol       Date:  2022-09       Impact factor: 8.678

2.  Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial.

Authors:  Sanne I Stegwee; Ângela J Ben; Mohamed El Alili; Lucet F van der Voet; Christianne J M de Groot; Judith E Bosmans; Judith A F Huirne
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

3.  Effect of single- and double-layer cesarean section closure on residual myometrial thickness and isthmocele - a systematic review and meta-analysis

Authors:  Greg J Marchand; Ahmed Masoud; Alexa King; Stacy Ruther; Giovanna Brazil; Hollie Ulibarri; Julia Parise; Amanda Arroyo; Catherine Coriell; Sydnee Goetz; Ashley Christensen; Katelyn Sainz
Journal:  Turk J Obstet Gynecol       Date:  2021-12-24

4.  Laparoscopic Isthmocele Repair: Efficacy and Benefits before and after Subsequent Cesarean Section.

Authors:  Stavros Karampelas; Georges Salem Wehbe; Laurent de Landsheere; Dominique A Badr; Linda Tebache; Michelle Nisolle
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.